- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT01492595
Screening of Children in Household Contact With Adult TB Patients in Mbarara Hospital, Uganda (TBcontact)
Screening of Children in Household Contact With Adult TB Patients in Mbarara Hospital, Uganda: An Open Cohort of Children <5 Years in Contact With Newly Diagnosed Adult TB Cases in Mbarara Hospital
Studieoversigt
Status
Betingelser
Detaljeret beskrivelse
Because children with tuberculosis (TB) are usually smear-negative and therefore less infectious, they are generally not considered a public health risk. Up to 70% of children living in the same household with an adult with infectious TB will become infected, and more than 20% of them will develop active TB disease, usually within 12 months. The individual risk of developing disease once infected is highest in children <5 years. In addition, children under 5 years are at higher risk of developing disseminated forms of TB. The impact of childhood TB is worsened by co-infection with HIV. Contact tracing, investigation and prophylaxis of childhood contacts of adult TB cases are widely recommended but rarely practiced in developing countries. The World Health Organization recommends that all NTPs screen household contacts for symptoms of disease and offer isoniazid preventive therapy (i.e. daily isoniazid for at least 6 months) to children aged less than 5 years and to all HIV-infected children who are household contacts. In Mbarara, an area with a high incidence of TB, no program currently exists for the routine investigation of child contacts of adult pulmonary TB cases. Almost all child TB cases registered are found through the evaluation of symptomatic children, often long after the adult source-cases have been investigated and treated. The number of adult cases with pulmonary TB, together with the population structure in Mbarara (>50% of the total population being children) suggests that the number of childhood TB cases is probably higher than current hospital records indicate.
The proposed study aims to establish a pilot program through a prospective cohort study offering routine contact tracing, investigation and prophylaxis for LTBI, and treatment of TB disease to children <5 years living in the same household as adults diagnosed with smear/culture-positive pulmonary TB in Mbarara Regional Referral Hospital. The study will also generate much needed data on the utility of simple symptom-based screening of child contacts for TB disease in areas where access to radiological examination and tuberculin skin test are limited and on the efficacy and safety of IPT, in a region with a significant problem of HIV co-infection.
Children aged 1 month to 5 years living in the same household (a house or cluster of houses on the same plot) with a newly diagnosed adult case of smear and/or culture-positive TB will be eligible for the study. Children will undergo a physical examination, chest Xray, tuberculin skin test and specimen collection in case of symptoms. Children will then be classified as active TB, TB infected and non infected cases. TB infected and non infected children will receive 6 months isoniazid prophylaxis with monthly monitoring of acceptability and tolerability. A final clinical assessment will be performed at 9 months. A total of 577 children contacts will be enrolled.
Undersøgelsestype
Tilmelding (Faktiske)
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Prøveudtagningsmetode
Studiebefolkning
Beskrivelse
Inclusion Criteria:
- Any child who has lived in the same household with the index case continuously for at least 2 weeks within the 3-month period immediately preceding the diagnosis of smear- positive or culture-positive TB in the index case.
- Informed consent signed by the parent or legal guardian
- Living within a 2-hour radius of Mbarara town
Exclusion Criteria:
- Child currently receiving anti-tuberculosis treatment
- Child has received a full course of anti-TB treatment within the last 6 months
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
Proportion of <5 year-old child contacts classified as active TB disease, LTBI or no infection
Tidsramme: Baseline
|
Baseline
|
Sekundære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
Number of children <5 years exposed to TB in the household of adult index cases
Tidsramme: Baseline
|
Baseline
|
|
Number of contacts identified as active TB basing on a symptom-based approach compared with those based on chest radiography
Tidsramme: 9 months
|
9 months
|
|
Proportion of contacts with HIV co-infection classified as non infected, LTBI or active TB
Tidsramme: 9 months
|
9 months
|
|
Median duration of exposure to symptomatic source case among the contacts in the various classes
Tidsramme: Baseline
|
Baseline
|
|
Association of various risk factors with the final classification of contacts after assessment
Tidsramme: 9 months
|
9 months
|
|
Proportion of children with LTBI successfully treated (prevented from developing active TB disease) among HIV-infected and uninfected children
Tidsramme: 9 months
|
9 months
|
|
Proportion of children with no TB infection or disease successfully treated (prevented from developing active TB disease or LTBI)
Tidsramme: 9 months
|
9 months
|
|
Proportion of adverse events on treatment of TB disease, LTBI and TB exposure
Tidsramme: 9 months
|
9 months
|
|
Adherence to IPT regimens
Tidsramme: 9 months
|
9 months
|
Samarbejdspartnere og efterforskere
Sponsor
Samarbejdspartnere
Efterforskere
- Ledende efterforsker: Julius Kiwanuka, MD, Mbarara University of Science and Technology
Datoer for undersøgelser
Studer store datoer
Studiestart
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Skøn)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- Epicentre/MBA/2011/TBcontact
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Tuberkulose
-
Nagasaki UniversityIkke rekrutterer endnuTuberkulose | Mycobacterium Tuberculosis | LungetuberkuloserKenya
-
University Children's Hospital BaselUniversity Hospital, Geneva; University Hospital Inselspital, Berne; Kantonsspital... og andre samarbejdspartnereRekrutteringTuberkulose | Mycobacterium TuberculosisSchweiz
-
National Institute of Allergy and Infectious Diseases...AfsluttetMycobacterium TuberculosisBrasilien
-
The University of Texas Health Science Center,...National Institute of Allergy and Infectious Diseases (NIAID)AfsluttetMycobacterium TuberculosisForenede Stater, Colombia, Mexico
-
National Institute of Allergy and Infectious Diseases...Aktiv, ikke rekrutterendeOpportunistiske infektioner | Mycobacterium Tuberculosis | Ikke-tuberkuløse mykobakterierThailand, Kina, Taiwan
-
Johns Hopkins UniversityAfsluttetMycobacterium TuberculosisForenede Stater
-
National Institute of Allergy and Infectious Diseases...Afsluttet
-
Assistance Publique - Hôpitaux de ParisViatris Inc.Ikke rekrutterer endnuAntibiotikaresistens | Mycobacterium Tuberculosis | MDR-TB | Tuberkulose Multi Drug Resistant ActiveFrankrig
-
National Institute of Allergy and Infectious Diseases...Afsluttet
-
François SpertiniUniversity of OxfordAfsluttetTuberkulose | Mycobacterium Tuberculosis, Beskyttelse modSchweiz